Study Stopped
Poor patient compliance
The Effect of Mindfulness/Meditation on Post-operative Pain and Opioid Consumption
1 other identifier
interventional
55
1 country
1
Brief Summary
The objective of this study is to examine the effectiveness of mindfulness/meditation using the Headspace App on post-operative pain and opioid consumption in patients after arthroscopic rotator cuff repairs, biceps tenodesis, and Mumford procedures.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Sep 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2020
CompletedFirst Submitted
Initial submission to the registry
February 2, 2021
CompletedFirst Posted
Study publicly available on registry
April 22, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2021
CompletedFebruary 8, 2024
February 1, 2024
1 year
February 2, 2021
February 6, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (8)
visual analog scale
single-item measure of pain and consists of a 100 millimeter (mm) horizontal line with the labels "No Pain" at the leftmost portion and "Worst Pain" at the rightmost portion of the line
2 weeks post-op
visual analog scale
single-item measure of pain and consists of a 100 millimeter (mm) horizontal line with the labels "No Pain" at the leftmost portion and "Worst Pain" at the rightmost portion of the line
6 weeks post-op, 3months post-op and 6 months post-op
visual analog scale
single-item measure of pain and consists of a 100 millimeter (mm) horizontal line with the labels "No Pain" at the leftmost portion and "Worst Pain" at the rightmost portion of the line
3months post-op
visual analog scale
single-item measure of pain and consists of a 100 millimeter (mm) horizontal line with the labels "No Pain" at the leftmost portion and "Worst Pain" at the rightmost portion of the line
6 months post-op
number of opioid pills
number of pills taken at each time point
2 weeks post-op
number of opioid pills
number of pills taken at each time point
6 weeks post-op
number of opioid pills
number of pills taken at each time point
3 months post-op
number of opioid pills
number of pills taken at each time point
6months post-op
Secondary Outcomes (12)
compliance of the intervention in the MM groups which will be tracked via the Headspace application.
2 weeks post-op
compliance of the intervention in the MM groups which will be tracked via the Headspace application.
6 weeks post-op
compliance of the intervention in the MM groups which will be tracked via the Headspace application.
3 months post-op
compliance of the intervention in the MM groups which will be tracked via the Headspace application.
6 months post-op
Patient reported out comes :Single Assessment Numeric Evaluation (SANE)
2 weeks post-op
- +7 more secondary outcomes
Study Arms (2)
control (CON)
ACTIVE COMPARATORwill receive the usual standard of care post-operative pain pills for the involved shoulder (Control Group)
Mindfulness/Meditation (MM)
EXPERIMENTALwill receive the usual standard of care post-operative pain pills for the involved shoulder with the addition of access to the Headspace application for mindfulness/meditation (Mindfulness/Meditation Group)
Interventions
Patients will receive access to head space meditation application in addition to standard pain medication post surgery.
Standard post-op pain medication
Eligibility Criteria
You may qualify if:
- years and older
- Status post shoulder arthroscopy for rotator cuff repair, biceps tendinopathy, and/or Mumford Procedure
You may not qualify if:
- Less than 18 years old
- History of shoulder osteoarthritis
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Kerlan Jobe
Los Angeles, California, 90045, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Michael Banffy, MD
Cedar Sinai -Kerlan Jobe
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator
Study Record Dates
First Submitted
February 2, 2021
First Posted
April 22, 2021
Study Start
September 1, 2020
Primary Completion
September 1, 2021
Study Completion
September 1, 2021
Last Updated
February 8, 2024
Record last verified: 2024-02
Data Sharing
- IPD Sharing
- Will not share